Record 045 · Therapeutics · 2017
50%17.45.X
Cellino
Cellino
“Automated iPSC manufacturing — cells as a foundry, not a benchtop.”
Cellino uses AI and lasers to make autologous iPSCs at scale. Regenerative infrastructure on the Series A therapeutics band.
On the TTI therapeutics row, Series A.
Series A. Filed from the Top Tier Impact landscape.
- Autologous iPSC foundry
- Laser automation
Stem cells, as a factory.
